Abstract
Introduction
Diabetes is a disabling disease due to multiple and associated mechanisms. 1 Previously, variations in blood glucose levels have been considered responsible for many of the consequences of diabetes-related disease. However, other vascular risk factors, socio-economic conditions and frequent associated diseases are all involved in the alteration of autonomy and quality of life of patients with diabetes.
Diabetes mellitus is an age-associated disease: at least 10% of community-leaving people older than 65 years and 15% of those leaving in care homes in Europe have a diabetes diagnosis. 2 Furthermore, in France, among a representative sample of people with a reimbursement for anti-diabetic drugs the proportion of subjects older than 65 years was 50% (Entred 2007 study) 3 with an increasing proportion of people older than 70 years since 2001. In Europe, we are facing increasing costs for care due to diabetes. 4 This increase in costs could be attributed to both an increase in the number of new patients and to their better survival, even with complications or poor quality of life. The question of the quality of care in the perspective of prevention is therefore crucial.
Older patients with diabetes are more likely to be exposed to a combination of diabetes and related disease and other age-associated disorders. Thus, many are frail and increased care should be provided in this perspective. 5 In this paper we intend to examine the influence of disability in older people with diabetes and its consequences on health and social care organisations.
Potential mechanisms of disability progression linked to diabetes
As with other chronic diseases, quality of life is impaired with diabetes 6 and particularly the physical part of quality of life. 7 With ageing, disability prevalence increases and diabetes may have an effect on premature ageing. According to a majority of cross-sectional studies in older people, diabetes is associated with an increase in dependency for activities of basic and instrumental daily living and mobility limitation. 1, 8 Furthermore, some geriatric syndromes are more frequent, such as falls and incontinence. In the cohort of the Nurses' Health Study, which was followed up for 20 years, the risk for urine leakage was increased in women with diabetes. In particular, severe incontinence was more frequent when insulin treatment was used. 9 Gait pattern alterations have been shown in a cross-sectional study from the Baltimore Longitudinal Study assessing 26 subjects with diabetes and without neuropathy compared with 160 older subjects without diabetes, suggesting complex determinants. 10 In women older than 67 years enrolled in the Study of Osteoporotic Fractures, the risk of falling associated with diabetes was particularly increased with insulin treatment. 11 A longitudinal sub-study of the CardioVascular Health Study has shown that high blood pressure, with or without a further control during the follow-up, was associated with increased risk of gait speed decline. 12 There were no associations in this small Patterns of dependency may differ according to diabetes characteristics and to complications or associated conditions. Within subjects of any age with diabetes from the Fremantle cohort, independent risk factors of becoming limited for mobility were older age, smoking, insulin treatment, albuminuria, neuropathy, arthritis, unmarried state and lack of physical activity. 13 However, baseline HbA 1C , lipid parameters and lipid lowering drugs, were not associated with mobility limitation in any way. On the other hand, for non-mobility basic activities of daily living, disability was predicted by older age, cerebrovascular disease, mobility problems, depression and socio demographic factors, but not by HbA 1C , lipid parameters and lipid lowering drugs.
Muscle strength seems reduced in people of any age with diabetes and muscle strength decreases at a higher rate than with other people. 14 In the Health, Aging and Body Composition study, muscle strength was also decreased despite an increase in muscle mass compared with other participants. There was an inverse relationship between strength and HbA 1C . 15 However, a confounding factor might have been the duration of diabetes because the relationships between strength and diabetes duration was in fact similar to those of strength and HbA 1C within the same cohort. 16 We can speculate that besides the consequences of diabetes complications and associated diseases, muscle metabolism alterations may occur explaining the decrease in muscle quality. 1 Muscle mitochondrial oxidative phosphorylation may also be impaired due to insulin resistance and oxidative stress. The decrease in muscle strength could be one determinant of the increased risk of gait alterations 17 and thus to the risk of mobility limitations.
Alterations in mental performance are also a potential important mechanism of disability progression in people with diabetes. People with diabetes cumulate multiple causes of cognitive alterations and depression. 18, 19 Insulin resistance and hypertension may be at the origin of cognitive impairment before overt diabetes. Indeed, there is evidence of executive functioning alteration in the metabolic syndrome and diabetes. 18 Large size population-based studies including at least 9,000-10,000 subjects like the Three Cities Study have provided evidence of an excess risk of dementia of any type (but not Alzheimer's) in subjects with metabolic syndrome or diabetes. 20 The underlying mechanisms of cognitive and mood impairment appear to involve both microangiopathy and cortical atrophy. Hypertension and ageing that are frequently associated with diabetes are major determinants of cerebral microangiopathy. 21, 22 It has been shown in a sample of 68 patients with diabetes with a mean age of 65 years that white matter changes were correlated with microalbuminuria but not with clinical microvascular complications; 23 hypertension, both systolic and diastolic, is a major determinant of microalbuminuria. 24 In contrast, after 75 years of age, the effects of known risk factors compared with the absence of these factors on leucoaraiosis are less or not visible in cerebral imaging studies. 19 Hypertension is also a determinant of cortical atrophy. 21 In a cross-sectional study, diabetes was also associated with an increased rate of cortical atrophy, and particularly in the frontotemporal regions. 25 Two longitudinal studies have also shown that cortical atrophy progression was increased in older subjects with diabetes compared with other subjects. 26, 27 In younger people (mean age 60 years) with diabetes, hippocampal atrophy progression appeared even faster. 28 In people with diabetes, depression is also more common. 29 An MRI brain study in a sample of people with diabetes has shown a more severe cortical prefrontal atrophy in those with depression. 30 An independent effect of hyperglycaemia on Alzheimer's dementia incidence has been shown. 31 According to two longitudinal studies, subjects with undiagnosed diabetes or a high level of blood glucose at baseline have suffered from an increased incidence of dementia independent of other vascular risk factors. 32, 33 Older age seems to decrease the higher risk of dementia since the burden of high blood glucose was not visible in subjects older than 85 years. 34 In summary, people with diabetes often present with a constellation of vascular risk factors, including hypertension, insulin resistance and hyperglycaemia, that increase the risk of mobility limitation, cognitive impairment and disability for daily living activities. However, in people older than 80 years, the differences between those with or without diabetes are less clear cut in published data.
Prevention targets
In people with diabetes, hypertension seems an important target of disability prevention with an expected impact on cardiovascular diseases, diabetes complications and cognition or dementia.
During 6 years of follow-up of the Health, Aging and Body Composition study which included subjects aged 70-79 years, there were no effects of either angiotensin inhibitors or statins, alone or in combination on the course of mobility limitations. In this study, people with diabetes (about 15%) were more often using both of these drugs. 35 A large-size longitudinal study did not demonstrate an effect within the general population of statin use and incident frailty. 36 The effect seems neutral; however, statins have potential deleterious effect on muscle function. In a cross-sectional study of 500 older people (12% with diabetes), statin use in half of them was related to a worse health status. There was no evidence of alteration of strength, balance or fall history associated with statin use. 37 A decrease in muscle strength in post-rehabilitation patients has been reported after prescription of statin and with recovery after the withdrawal of the drug. 38 An individual assessment of the change associated with this prescription is therefore required.
The effect of blood glucose control on disability progression has not been investigated in detail in older patients with diabetes. In the Health, Aging and Body Composition study there were no reductions in the risk of fall associated with lower HbA 1C during five years of follow-up. In those using insulin, HbA 1C lower than 6% was associated with an increased risk of falling. 39 In comparison, another observational study in 119 older subjects with diabetes showed that subjects with 'better' glycaemic control displayed less lower limb function alteration that others during 18-36-month of follow-up. The two groups had been separated into better or worse blood glucose control on the basis of both a mean level lower and lower level of monthly variations. A mean of 6.5% (48 mmol/mol) was compared with a mean of 8% (64 mmol/mol) for HbA 1C . However, the baseline lower limb function was worse in those with the worse blood glucose control and this decrease may be associated with the quality of the control. 40 Interventional controlled studies, sometimes of long duration (10 years) using statins, antihypertensive medications or aiming for ambitious blood glucose control were without effect on cognition in patients with diabetes. 18, 41, 43 However, a multifactorial 12-month intervention in a young population with diabetes (85%) or coronary heart disease were able to decrease the rate of disability and to improve quality of life. This intervention was not blind but focused on blood pressure, blood glucose, LDL cholesterol correction to target and treatment of depression. 44 In another young cohort with a 20% rate of diabetes, beta-blocker therapy was associated with a lower decrease in autonomy for daily living activities. 45 Thus, the effect of the control of blood glucose and associated factors on the determinants of disability may differ according to the age of the patients and possibly to diabetes duration.
Consequences for clinical practice Patient assessment
Older patients with diabetes are likely to present with functional limitations, both mental and physical. Particularly, their cognitive functioning often seems impaired and affects the specific domains very useful for self diabetes management: executive functioning (mental speed, planning ability, attention). 18 Thus, it is recommended to perform a gerontological assessment in older people with diabetes. 46, 47 Gerontological assessment aims to prevent autonomy loss. In people with diabetes (table 1) it could include mental health (cognition and mood), autonomy (mobility, basic and instrumental activities of daily living), gait and balance, nutritional status (anthropometry, risk for undernutrition, oral health and swallowing function), comorbidity and complications of diabetes, pharmacy, renal function and routine biology, pain and social status. The results of this assessment may lead to treatment revision or physiotherapy prescription and social help. However, a comprehensive assessment mobilises important resources.
A simple test to detect frail people with diabetes who need a comprehensive assessment is not yet available. The SPPB explores gait speed for a short distance (4 m), lower limb strength (chair-rise) and balance. The score range is 0-12 with higher scores indicating better performance and less functional limitation. 48 A score equal or below 9 has been proposed for frailty screening. 49 The equivalent for a non-dementia cognitive impairment screening does not really exist; the sensitivity and specificity of the MMSE score for other purposes than dementia screening is low. A comprehensive battery to test executive functioning might include the Digit Symbol Substitution Test (attention, psychomotor performance and perceptual organisation), the Trail Making Test B (attention, visual scanning, sequential abilities and executive functioning) and word category denomination (psychomotor speed). From a pragmatic point of view, cognitive testing should target the task involved in the diabetes self-management. For example, the clock drawing test is easy to administer and is related to the ability to self manage diabetes. 50 Subjects are presented with a circle and asked to insert the numbers as if it were a clock face and then place the hour and minute hands at a set time ('10 past 11'). This test requires understanding, memory, visuoconstructive, planning and organisational ability. The adequate keeping of a digital glycaemia booklet needs this ability. To shortly assess the ability to manage insulin injection a test based on rapid mental calculation, the TTMC was developed. 51 We propose a set of criteria to screen people who may benefit from a comprehensive gerontological assessment (table 2) .
Aims of care
Informed by this patient assessment process, it is possible to construct a care plan with the patient and the care-giver if any, based on a benefit-risk ratio. The safety issues are clearly of major importance. 47 
Education for older patients with diabetes
An adapted educational programme for older people with diabetes, focused on their learning capacities has shown efficiency for blood glucose and vascular risk factors control and for complications prevention. 52 Due to the usual difficulties of this population the involvement of a care-giver is often necessary. 53 Besides the general principles of education in diabetes, a baseline physical and cognitive assessment is necessary, sometimes with assessment of the potential care-giver.
Disease management
Long-term phone support for disease management and improvement of lifestyle (physical activity and nutrition) has shown efficiency in the prevention of hospitalisations and in improvement of quality of life of older community-living patients with diabetes. 54 A nurse case manager devoted to diabetes, similar to a case manager for heart failure or Alzheimer's disease could be very efficient in the general follow-up of the disease. 55 This method of follow-up comes after education and enhances the effects of it with a continuous adaptation to the present situation of the patient.
Conclusion
Older people with diabetes are highly heterogeneous and need adapted/informed care. Disability and quality of life impairment are frequent concerns and have a strong impact on disease management and goals. The assessment of disability and frailty therefore needs to be more efficient in disease management to address the individual needs of these patients.
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